Leake H A, Appleyard M N, Hartley J P
Department of Medicine, Brighton Health Care, U.K.
J Infect. 1994 May;28(3):319-22. doi: 10.1016/s0163-4453(94)92093-1.
Various formulations have been developed in an effort to reduce the toxicity of amphotericin B. We report a case of cryptococcal meningitis in a 31-year-old HIV-positive man which was successfully treated with amphotericin B lipid emulsion.